Cargando…
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
BACKGROUND: The present study was designed to test the hypothesis that inactivation of virtually any component within the pathway containing the BRCA1 and BRCA2 proteins would increase the risks for lymphomas and leukemias. In people who do not have BRCA1 or BRCA2 gene mutations, the encoded protein...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959234/ https://www.ncbi.nlm.nih.gov/pubmed/17683622 http://dx.doi.org/10.1186/1471-2407-7-152 |